Oxynov and the CTS 

OxyNov is a company focused on clinical innovation and on the commercialization of its oxygen therapy medical devices.

OxyNov sells freeO2 in European hospitals, a unique solution that revolutionizes oxygen therapy, the most widely administered treatment in hospitals.

Desjardins-Innovatech's investment and the support of the CTS come at the right time to support our ambitious plans to commercialize our devices in European and North American hospitals. We are pleased to be part of the CTS ecosphere.

Jean-Luc BalzerPresident, Oxynov

Project Images